Our data confirm that pregnant women with PVhave an increased risk of fetal loss. The high rate of advanced miscar-riage, related to the presence ofJAK2V617F mutation, seems to bereduced by anti-thrombotic therapy. The correct use of vene-section has to be established in this setting of patients. Due to the rar-ity of this condition, collaborative studies are required to better clarifythe best management of pregnancy in PV

Pregnancy outcome and management of 25 pregnancies in women with polycythemia vera.

Rumi E;Cavalloni C;Cazzola M;
2018-01-01

Abstract

Our data confirm that pregnant women with PVhave an increased risk of fetal loss. The high rate of advanced miscar-riage, related to the presence ofJAK2V617F mutation, seems to bereduced by anti-thrombotic therapy. The correct use of vene-section has to be established in this setting of patients. Due to the rar-ity of this condition, collaborative studies are required to better clarifythe best management of pregnancy in PV
2018
The Hematology category covers resources concerned with blood, blood-forming tissues, bone marrow, plasma, and transfusions. Coverage also includes resources on specialties such as hemophilia, leukemia, and lymphoma.
Esperti anonimi
Inglese
Internazionale
ELETTRONICO
93
9
234
235
2
pregnancy, jak2, polycythemia
https://www.ncbi.nlm.nih.gov/pubmed/29989197
no
6
info:eu-repo/semantics/article
262
Bertozzi, I; Rumi, E; Cavalloni, C; Cazzola, M; Fabris, F; Randi, Ml
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1321808
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 21
social impact